Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  De Almeida, Amanda Roberta ^a   Monte Alegre, Sarah ^a   Zanini, Michele Bianca ^a   Souza, Aglécio Luiz ^a   Etchebehere, Maurício ^a   Gontijo, José Antonio Rocha ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Adiponectin; Blood pressure; Inflammation; Metabolic syndrome; Obesity; Renal function

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; LEPTIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERINSULINEMIA; IMMUNOASSAY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SYNTHESIS; KIDNEY DYSFUNCTION; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREHYPERTENSION; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; SODIUM RETENTION; SODIUM URINE LEVEL; VOLUNTEER;

EID: 84903749303     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-11-25     Document Type: Article

References (48)

1. A potential decline in life expectancy in the United States in the 21st century. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS, N Engl J Med 2005 352 1138 1145 10.1056/NEJMsr043743 15784668 (Pubitemid 40365358)
2. Obesity: considerations about etiology, metabolism, and the use of experimental models. Pereira-Lancha LO, Campos-Ferraz PL, Lancha AH Jr, Diabetes Metab Syndr Obes. 2012 5 75 87 22570558
3. Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. Parker DR, Weiss ST, Troisi R, Cassano PA, Vokonas PS, Lansberg L, Am J Clin Nutr 1993 58 129 136 8338037 (Pubitemid 23227881)
4. Obesity. Haslam DW, James WP, Lancet 2005 366 1197 1209 10.1016/S0140-6736(05)67483-1 16198769 (Pubitemid 41393598)
5. Time-course morphological and functional disorders of the kidney induced by long-term high-fat diet intake in female rats. Pinhal CS, Lopes A, Torres DB, Felisbino SL, Rocha Gontijo JA, Boer PA, Nephrol Dial Transplant 2013 28 10 2464 2476 10.1093/ndt/gft304 24078639
6. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Grassi G, Hypertens Res 2006 29 839 847 10.1291/hypres.29.839 17345783 (Pubitemid 46062115)
7. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Aroor AR, McKarns S, DeMarco FG, Jia G, Sowers JR, Metabolism 2013 http://dx.doi.org/10.1016/j.metabol.2013.07.001
8. Exercise capacity and progression from prehypertension to hypertension. Faselis C, Doumas M, Kokkinos JP, Panagiotakos D, Kheirbek R, Sheriff HM, Hare K, Papademetriou V, Fletcher R, Kokkinos P, Hypertension 2012 60 333 338 10.1161/HYPERTENSIONAHA.112.196493 22753224
9. Overweight female rats selectively breed for low aerobic capacity exhibit increased myocardial fibrosis and diastolic dysfunction. DeMarco VG, Johnson MS, Ma L, Pulakat L, Mugerfeld I, Hayden MR, Garro M, Knight W, Britton SL, Koch LG, Sowers JR, Am J Physiol Heart Circ Physiol 2012 302 1667 H1682 10.1152/ajpheart.01027.2011 22345570
10. Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice. DeMarco VG, Ford DA, Henriksen EJ, Aroor AR, Johnson MS, Habibi J, Ma L, Yang M, Albert CJ, Lally JW, Ford CA, Prasannarong M, Hayden MR, Whaley-Connell AT, Sowers JR, Endocrinology 2013 154 159 171 10.1210/en.2012-1835 23142808
11. The kidney, hypertension, and obesity. Hall JE, Hypertension 2003 41 625 633 10.1161/01.HYP.0000052314.95497.78 12623970 (Pubitemid 36314565)
12. Insulin resistance: metabolic mechanisms and consequences in the heart. Abel ED, O'Shea KM, Ramasamy R, Arterioscler Thromb Vasc Biol 2012 32 2068 2076 10.1161/ATVBAHA.111.241984 22895668
13. Obesity cardiomyopathy: pathogenesis and pathophysiology. Wong C, Marwick TH, Nat Clin Pract Cardiovasc Med 2007 4 436 443 10.1038/ncpcardio0943 17653116 (Pubitemid 47189016)
14. Adiponectin, cardiovascular function, and hypertension. Wang ZV, Scherer PE, Hypertension 2008 51 8 14 10.1161/HYPERTENSIONAHA.107.099424 17998473 (Pubitemid 350307092)
15. Reduced renal sodium excretion in primary hypertensive patients after an oral glucose load. Gontijo JA, Muscelli EO, Braz J Med Biol Res 1996 29 10 1291 1299 9181099 (Pubitemid 126496895)
16. Insulin resistance and myocardial hypertrophy in the attenuated reduction in mean arterial pressure after a glucose load in hypertensive patients. Souza ML, Berardi EO, Gontijo JA, Leme Júnior CA, Cavicchio JR, Saad MJ, Braz J Med Biol Res 1995 28 9 967 972 8580884
17. Urinary acidification and renal sodium handling in a case of renal Fanconi syndrome. Tanaka RC, Gontijo JA, Nephron 1998 78 3 339 340 10.1159/000044949 9546700 (Pubitemid 28102618)
18. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 7 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
19. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ, J Clin Endocrinol Metab 2000 85 7 2402 2410 10.1210/jcem.85.7.6661 10902785 (Pubitemid 32269192)
20. Acute intracerebroventricular insulin microinjection after nitric oxide synthase inhibition of renal sodium handling in rats. Furlan FC, Marshall PS, Macedo RF, Carvalheira JB, Michelotto JB, Gontijo JA, Life Sci. 2003 72 2561 2569 10.1016/S0024-3205(03)00170-X 12672502 (Pubitemid 36369697)
21. Maternal undernutrition and the offspring kidney: from fetal to adult life. Mesquita FF, Gontijo JA, Boer PA, Braz J Med Biol Res 2010 43 11 1010 1018 10.1590/S0100-879X2010007500113 21049242
22. Insulin resistance: the link between obesity and cardiovascular disease. Reaven GM, Med Clin North Am 2011 95 875 892 10.1016/j.mcna.2011.06.002 21855697
23. Epidemiology of the metabolic syndrome in the USA. McCullough AJ, J Dig Dis 2011 12 333 340 10.1111/j.1751-2980.2010.00469.x 21091931
24. Insulin resistance and heart failure: molecular mechanisms. Aroor AR, Mandavia CH, Sowers JR, Heart Fail Clin 2012 8 609 617 10.1016/j.hfc.2012.06.005 22999243
25. Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Stanhope KL, Annu Rev Med 2012 63 329 343 10.1146/annurev-med-042010-113026 22034869
26. The genetics of childhood obesity and interaction with dietary macronutrients. Garver WS, Newman SB, Gonzales-Pacheco DM, Castillo JJ, Jelinek D, Heidenreich RA, Orlando RA, Genes Nutr 2013 8 271 287 10.1007/s12263-013- 0339-5 23471855
27. The genetic and epigenetic basis of type 2 diabetes and obesity. Drong AW, Lindgren CM, McCarthy MI, Clin Pharmacol Ther. 2012 92 707 715 10.1038/clpt.2012.149 23047653
28. Insulin resistance in essential hypertension. Ferrannini E, Buzzicoli G, Bonadonna RN, Eng J Med. 1985 317 350 357 (Pubitemid 17118813)
29. Relation between blood pressure, weight, and plasma sugar serum insulin levels in schoolchildren age 9-12 years in Westland. Florey CV, Uppal S, Lowy C, Holland. Br Med J. 1976 1 1368 1371 10.1136/bmj.1.6022.1368
30. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. Minicardi V, Camellini L, Belloidi G, Ferrannini E, J Clin Endocrinol Metabol. 1986 62 1302 1304 10.1210/jcem-62-6-1302 (Pubitemid 16085296)
31. Diabetes mellitus and vascular disease. Sowers JR, Hypertension 2013 61 943 947 10.1161/HYPERTENSIONAHA.111.00612 23595139
32. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. Witteles RM, Fowler MB, J Am Coll Cardiol. 2008 51 93 102 10.1016/j.jacc.2007.10.021 18191731
33. Oxidative stress in the cardiorenal metabolic syndrome. Whaley-Connell A, Sowers JR, Curr Hypertens Rep. 2012 14 360 365 10.1007/s11906-012-0279-2 22581415
34. Adipose tissue: from lipid storage compartment to endocrine organ. Scherer PE, Diabetes. 2006 55 1537 1545 10.2337/db06-0263 16731815 (Pubitemid 44324105)
35. Immunity as a link between obesity and insulin resistance. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ, Mol Aspects Med. 2012 33 26 34 10.1016/j.mam.2011.10.011 22040698
36. Inflammatory mechanisms in obesity. Gregor MF, Hotamisligil GS, Annu Rev Immunol. 2011 29 415 445 10.1146/annurev-immunol-031210-101322 21219177
37. The gut microbiota, obesity and insulin resistance. Shen J, Obin MS, Zhao L, Mol Aspects Med 2013 34 39 58 10.1016/j.mam.2012.11.001 23159341
38. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Brown K, DeCoffe D, Molcan E, et al. Nutrients. 2012 4 1095 1119 10.3390/nu4081095 23016134
39. Adiponectin replenishment ameliorates obesity-related hypertension. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I, Hypertension. 2006 47 1108 1116 10.1161/01.HYP.0000222368.43759.a1 16651465 (Pubitemid 44289168)
40. Hypoadiponectinemia is an independent risk factor for hypertension. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T, Hypertension. 2004 43 1318 1323 10.1161/01.HYP.0000129281.03801.4b 15123570 (Pubitemid 38691756)
41. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED, Lam TH, Lam KS, Hypertension. 2007 49 1455 1461 10.1161/HYPERTENSIONAHA.107.086835 17452504 (Pubitemid 46809394)
42. Renal sodium handling after noradrenergic stimulation of the lateral hypothalamic area in rats. Gontijo JA, Garcia WE, Figueiredo JF, Silva-Netto CR, Furtado MR, Braz J Med Biol Res. 1992 25 937 942 1342841
43. The sympathetic nervous system and the metabolic syndrome. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA, J Hypertens. 2007 25 909 920 10.1097/HJH.0b013e328048d004 17414649 (Pubitemid 46573105)
44. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Tanida M, Shen J, Horii Y, Matsuda M, Kihara S, Funahashi T, Shimomura I, Sawai H, Fukuda Y, Matsuzawa Y, Nagai K, Exp Biol Med (Maywood). 2007 232 390 397 17327472 (Pubitemid 46334055)
45. Insulin increases loop segment chloride reabsorption in the euglycemic rat. Kirchner KA, Am J Physiol. 1988 255 1206 F1213 3059825
46. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal human. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL, JCI. 1991 87 2246 2252 10.1172/JCI115260 2040704
47. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Abboud FM, Harwani SC, Chapleau MW, Hypertension. 2012 59 755 762 10.1161/HYPERTENSIONAHA.111.186833 22331383
48. Vascular inflammatory cells in hypertension. Harrison DG, Marvar PJ, Titze JM, Front Physiol. 2012 3 128 22586409